Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

2685786-28-9

2685786-28-9 structure

2685786-28-9 structure

Name: Neuraminidase-IN-11
Chemical Name: Neuraminidase-IN-11
CAS Number: 2685786-28-9
Molecular Formula: C₂₆H₃₄N₂O₅S
Molecular Weight: 486.62
Catalog: Signaling Pathways Anti-infection Influenza Virus
Create Date: 2022-09-16 01:57:29
Modify Date: 2024-04-09 16:42:14
Neuraminidase-IN-11 (15e) is a potent and selective neuraminidase (NA) inhibitor with the IC50 values of 4.7 nM, 8.46 nM and 1.5 nM against H1N1, H5N1 and H5N8 NAs respectively[1].

Name	Neuraminidase-IN-11

Description	Neuraminidase-IN-11 (15e) is a potent and selective neuraminidase (NA) inhibitor with the IC50 values of 4.7 nM, 8.46 nM and 1.5 nM against H1N1, H5N1 and H5N8 NAs respectively[1].
Related Catalog	Signaling Pathways >> Anti-infection >> Influenza Virus Research Areas >> Infection
In Vitro	Neuraminidase-IN-11 (15e) (0-6 μM, 40 min)has anti-NA (Neuraminidase) activity against H1N1-H274Y mutant and H5N1-H274Y mutant with the IC50 values of 1.07 μM and 0.61 μM, respectively[1]. Neuraminidase-IN-11 (15e) (0-20 μM, 48 h) inhibits chicken embryo fibroblasts (CEFs) infected H5N1 or H5N8 with the IC50 values of 4.4 μM and 0.57 μM respectively, and inhibits Madin−Darby canine kidney (MDCK) cells infected H1N1 or H3N2 with the IC50 values of 0.05 μM and 12.65 μM respectively[1]. Neuraminidase-IN-11 (15e) has no significant inhibitory effect on the major CYP enzymes which acts on CYP1A2, CYP2C9 and CYP2C19 with the IC50 values of 28.9 μM, 47.3 μM and 47.8 μM, respectively[1]. The metabolic stability parameters of Neuraminidase-IN-11 (15e) in human liver microsomes (HLM)[1]. Parameters Neuraminidase-IN-11 (15e) t1/2 (min) >145 CLint(mic) (μL/min/kg) <9.6 CLint(liver) (mL/min/kg) <8.6 remaining (T = 60 min) (%) 79.3
In Vivo	Neuraminidase-IN-11 (15e) (oral administration, 50 mg/kg, every second day, 14 days) shows no significant change in body weight and no other toxic side effects in kunming mice[1]. Animal Model: Male Sprague−Dawley rat[1] Dosage: Administration: 2 mg/kg, i.v.; 20 mg/kg, p.o. Result: The pharmacokinetic parameters of Neuraminidase-IN-11 (15e) Parameters 15e (i.v.) 15e (p.o.) t1/2 (h) 0.213 0.863 Tmax (h) 0.083 0.5 Cmax (ng/mL) 7195 491 Vdss (mL/kg) 179 - CL 17.2 - F (%) - 1.58
References	[1]. Han Ju, et al. Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity. J Med Chem. 2022 Aug 8.

Molecular Formula	C₂₆H₃₄N₂O₅S
Molecular Weight	486.62

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.